Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event in Washington, D.C. Aurora Logo (CNW Group/Aurora Cannabis Inc.) "The opportunity ...

Aurora discovered a new source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa. Given this discovery, the company is set to develop powdery mildew-resistant plants.

Aurora Cannabis produces and sells a variety of cannabis products, including dried cannabis, oils, capsules, and topical treatments, primarily for medical patients. It also manufactures and sells ...

Projected to witness a CAGR of 22.5% from 2025 to 2035, the industry presents a highly favorable landscape for companies like Aurora Cannabis ACB. With the growing demand for cannabinoid-based ...

Aurora Cannabis shares jumped Thursday morning after the cannabis company said it has discovered a genetic resistance that protects its plants from crop disease. Shares rose 12% to 6.98 Canadian ...

Shares of Aurora Cannabis Inc. ACB rose 1.21% to $5.86 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.47% ...

EDMONTON, AB, March 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a ...